Open-Label Extension Study to Evaluate the Long Term Safety and Efficacy of ESK-001 in Plaque Psoriasis | MicrobiomeTrials← Back to trialsNCT05739435
Open-Label Extension Study to Evaluate the Long Term Safety and Efficacy of ESK-001 in Plaque Psoriasis
RecruitingPHASE2INTERVENTIONAL
Trial Details
Start: 2023-01-17Est. Completion: 2027-12-01
Enrollment target: 165 participants Locations- Investigator Site # 1029, Birmingham, Alabama, United States
- Investigator Site #1001, Phoenix, Arizona, United States
- Investigator Site # 1023, Rogers, Arkansas, United States
- Investigator Site #1021, Encinitas, California, United States
- Investigator Site #1018, Los Angeles, California, United States
- Investigator Site #1007, Santa Monica, California, United States
- Investigator Site #1002, Sherman Oaks, California, United States
- Investigator site # 1030, Fort Lauderdale, Florida, United States
- Investigator Site #1025, Hialeah, Florida, United States
- Investigator site # 1028, Miami, Florida, United States
- Investigator Site # 1013, Tampa, Florida, United States
- Investigator Site #1035, Macon, Georgia, United States
- Investigator Site #1043, Sandy Springs, Georgia, United States
- Investigator Site #1005, Rolling Meadows, Illinois, United States
- Investigator Site # 1011, Columbus, Indiana, United States
- Investigator Site #1027, South Bend, Indiana, United States
- Investigator SIte#1036, Overland Park, Kansas, United States
- Investigator Site #1017, Owensboro, Kentucky, United States
- Investigator Site #1026, Rockville, Maryland, United States
- Investigator Site #1010, Clarkston, Michigan, United States
- Investigator Site #1031, New Brighton, Minnesota, United States
- Investigator Site #1033, Norman, Oklahoma, United States
- Investigator Site #1019, Portland, Oregon, United States
- Investigator Site #1022, Philadelphia, Pennsylvania, United States
- Investigator Site # 1012, Rapid City, South Dakota, United States
- Investigator Site #1015, Houston, Texas, United States
- Investigator Site # 1006, San Antonio, Texas, United States
Other microbiome trials you might be interested in
Plaque PsoriasisBiologic AgentsRelapseInfluence Factors
In recent years, an increasing number of patients who have experienced poor efficacy or adverse drug reactions using tra…
Xi'an, ChinaEst. completion Dec 1, 2026
Metabolic DiseaseCardiovascular DiseaseInflammationPsoriasis
Background:
\- Cardiometabolic diseases are medical disorders that can occur together and affect the heart. They increa…
Bethesda, United StatesCompleted Jan 6, 2023
Investigator Site # 1041, South Jordan, Utah, United StatesInvestigator Site #2001, Edmonton, Alberta, CanadaInvestigator Site # 2008, Surrey, British Columbia, CanadaInvestigator Site #2003, Winnipeg, Manitoba, CanadaInvestigator Site #2006, London, Ontario, CanadaInvestigator Site # 2004, Mississauga, Ontario, CanadaInvestigator Site # 2007, North Bay, Ontario, CanadaInvestigator Site #2005, Oakville, Ontario, CanadaInvestigator Site #2009, Toronto, Ontario, CanadaInvestigator Site # 2002, Waterloo, Ontario, CanadaInvestigator Site # 2010, Québec, Quebec, Canada